HANNAH HOOVER: Open Payments
NPI 1497213227 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$585 in 32 payments from 14 companies in 2025. Trend: 2023 $398 · 2024 $369 · 2025 $585
Food & beverage: $585
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $162 |
| Sumitomo Pharma America, Inc. | 6 | $95 |
| AstraZeneca Pharmaceuticals LP | 4 | $75 |
| Exact Sciences Corporation | 2 | $45 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $30 |
| GlaxoSmithKline, LLC. | 1 | $29 |
| ABBVIE INC. | 1 | $27 |
| Abbott Laboratories | 1 | $24 |
| IBSA Pharma Inc. | 1 | $21 |
| Astellas Pharma US Inc | 1 | $17 |
Products named: GEMTESA, Wegovy, The Cologuard Plus Collection Kit, Rybelsus, AIRSUPRA, JARDIANCE, Ozempic, TRELEGY ELLIPTA.
Industry payments across TX — which companies pay providers there.
